The Centers for Medicare & Medicaid Services (CMS) proposed coverage with evidence development of artificial heart devices. CMS proposes to cover artificial heart devices in Medicare beneficiaries who are enrolled in Food and Drug Administration (FDA)-approved studies. The proposal relaxes a long-standing non-coverage policy, gives access to beneficiaries and promotes evidence development through FDA-approved studies of this advanced technology.

To view the entire Press Release, go to: http://www.cms.hhs.gov/apps/media/press_releases.asp.